Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: J Card Fail. 2017 Jul 14;23(9):690–696. doi: 10.1016/j.cardfail.2017.07.394

Table 1.

Participant characteristics in control and heart failure groups. Subjects were well matched for age, but the patients with HF were taller and heavier than the control subjects. No differences were observed between mean arterial pressure, hemoglobin, or estimated glomerular filtration rate (eGFR) but patients with HF had greater levels of NT-proBNP. Data are mean plus or minus standard error of the mean.

Control Heart Failure
N (female)           12 (4)     14 (2)
Age, y   65.1 ± 2.6 67.6 ± 3.0
Height, cm 168.5 ± 2.8 175.7 ± 2.7*
Weight, kg   70.8 ± 3.9   93.9 ± 3.8*
BMI, kg·m−2   24.7 ± 0.8   30.4 ± 1.1*
BSA, m2       1.8 ± 0.06       2.1 ± 0.05*
Mean arterial pressure, mmHg   87.9 ± 2.0 83.6 ± 2.8
Hemoglobin, g·dl−1   13.7 ± 0.3 13.7 ± 0.5
eGFR, ml·min−1·1.73−1·m−2   77.1 ± 4.7 70.2 ± 4.8
NT-proBNP, pg·ml−1     58.6 ± 13.1      1169 ± 298.9*
Left ventricular ejection fraction, %         – 33.0 ± 2.0
NYHA
 I         – 5
 II         – 6
 III         – 3
Medications
 Ace-Inhibitor         – 7
 Angiotension 2 blocker         – 5
 Beta blocker         – 13
 Digitalis         – 3
 Diuretic         – 10
*

P<0.05 control vs heart failure